ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 109 filers reported holding ANI PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $13,449,000 | +5.7% | 383,696 | +9.0% | 0.31% | -6.1% |
Q1 2021 | $12,722,000 | +28.9% | 352,014 | +3.6% | 0.33% | +3.5% |
Q4 2020 | $9,869,000 | +8.7% | 339,852 | +5.6% | 0.32% | -21.9% |
Q3 2020 | $9,083,000 | +0.5% | 321,975 | +15.3% | 0.41% | -13.8% |
Q2 2020 | $9,035,000 | -22.0% | 279,366 | -1.8% | 0.47% | -37.5% |
Q1 2020 | $11,588,000 | -33.9% | 284,437 | +0.0% | 0.75% | +0.5% |
Q4 2019 | $17,535,000 | -13.9% | 284,334 | +1.8% | 0.75% | -20.6% |
Q3 2019 | $20,360,000 | -11.5% | 279,360 | -0.2% | 0.94% | -11.8% |
Q2 2019 | $23,014,000 | +17.8% | 279,979 | +1.1% | 1.07% | +13.0% |
Q1 2019 | $19,531,000 | +109.3% | 276,879 | +33.6% | 0.95% | +77.1% |
Q4 2018 | $9,333,000 | +593.9% | 207,300 | +771.6% | 0.54% | +764.5% |
Q3 2018 | $1,345,000 | -66.0% | 23,785 | -61.3% | 0.06% | -68.4% |
Q4 2017 | $3,958,000 | +22.8% | 61,412 | 0.0% | 0.20% | +18.8% |
Q3 2017 | $3,224,000 | – | 61,412 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |